¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"group III fiber"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® muscle cell(=muscle fiber) ÇÑ±Û ±ÙÀ°¼¼Æ÷
¼³¸í   
  ±ÙÀ°Àº ¼öÀDZÙ(ÀǽĿ¡ ÀÇÇØ¼­ Á¶ÀýÀÌ °¡´ÉÇÑ ±ÙÀ°: ¿¹¸¦ µé¾î ´Ù¸®, ÆÈ, ¾ó±¼±ÙÀ° µî)°ú ºÒ¼öÀDZÙ(Àǽİú ¹«°üÇϰԠÁ¶ÀýÇÏÁö ¾Ê¾Æµµ ¿òÁ÷À̴ ±ÙÀ°: ¿¹¸¦ µé¾î ½ÉÀå±Ù, ¼ÒÈ­±â°ü¿¡ ºÐÆ÷Çϴ ±ÙÀ° µî)À¸·Î ³ª´©¾îÁö¸ç, ±ÙÀ°¼¼Æ÷ÀÇ ¸ð¾çÀº ´ÙÀ½°ú °°´Ù(¼öÀDZÙ, ºÒ¼öÀDZ٠¿Ü¿¡ ½ÉÀå¿¡ Àִ ½ÉÀå±ÙÀº ºÒ¼öÀDZٿ¡ ÇØ´çÇÏÁö¸¸ ±× ¸ð¾çÀº ¼öÀDZٰú °°¾Æ µû·Î ºÐ·ùÇÑ´Ù).
  
  ±ÙÀ°¼¼Æ÷
¿µ¹® blood group ÇÑ±Û Ç÷¾×Çü
¼³¸í   
  »ç¶÷ÀÇ ÀûÇ÷±¸ Ç¥¸é¿¡´Â ¿©·¯ °¡Áö Ç׿ø¼ºÀ» °¡Áø ¹°ÁúÀÌ Á¸ÀçÇÑ´Ù. Á鿪ÇÐÀû ¹ÝÀÀÀ» ÀÏÀ¸Å³ ¼ö Àִ ¹°ÁúÀ» Ç¥¸é¿¡ °¡Áö°í ÀÖ´Ù. ±×¸®°í »ç¶÷ÀÇ ÇǼӿ¡´Â À̰Ͱú ¹ÝÀÀÇÒ ¼ö°¡ Àִ Ç×üµµ Á¸ÀçÇÑ´Ù. »ç¶÷ÀÇ Ç÷¾×Àº À̰Ϳ¡ µû¶ó ¸î°¡Áö ÇüÀ¸·Î ºÐ·ùÇÒ ¼ö°¡ ÀÖ°í, À̰ÍÀ» Ç÷¾×ÇüÀ̶ó°í ÇÑ´Ù. Ç÷¾×ÇüÀº ÀûÇ÷±¸ Ç¥¸é¿¡ Àִ ¾î¶² ¹°ÁúÀ» ±âÁØÀ¸·Î ÇÏ´À³Ä¿¡ µû¶ó¼­ ¿©·¯ °¡Áö·Î ºÐ·ùµÉ ¼ö ÀÖ´Ù. ´ëÇ¥ÀûÀΠÇ÷¾×ÇüÀÇ ±¸ºÐ ¹æ¹ý¿¡´Â ABOÇ÷¾×Çü°ú RhÇ÷¾×ÇüÀÌ ÀÖ´Ù.
  
  1. ABO Ç÷¾×Çü
  
  °¡Àå ¸¹ÀÌ »ç¿ëµÇ°í Àִ Ç÷¾×Çü ±¸ºÐ¹ý. ÀûÇ÷±¸ Ç¥¸é¿¡´Â A, BÇüÀÇ µÎ °¡Áö ¹°ÁúÀ» Çϳª, È¤Àº µÑ, ¶Ç´Â Çϳªµµ °¡ÁöÁö ¾ÊÀ» ¼ö°¡ ÀÖ´Ù. ±×¸®°í ÇǼӿ¡´Â À̰Ͱú ¹ÝÀÀÇØ¼­ ÀûÇ÷±¸¸¦ ÆÄ±«Çϰųª ÀÀÁý½Ãų ¼ö Àִ ¹°Áú(Ç×ü)ÀÌ Á¸ÀçÇÑ´Ù. ¹°·Ð ÀÚ½ÅÀÇ ÀûÇ÷±¸°¡ °¡Áö°í Àִ ¹°Áú¿¡ ´ëÇÑ Ç×ü´Â Á¸ÀçÇÏÁö ¾Ê´Â´Ù.
  
  -AÇü Ç÷¾×Çü£­ÀûÇ÷±¸ Ç¥¸é¿¡ AÇ׿ø, Ç÷¾×¼Ó¿¡ B¿¡ ´ëÇÑ Ç×ü
  
  -BÇü Ç÷¾×Çü£­ÀûÇ÷±¸ Ç¥¸é¿¡ BÇ׿ø, Ç÷¾×¼Ó¿¡ A¿¡ ´ëÇÑ Ç×ü
  
  -ABÇü Ç÷¾×Çü£­ÀûÇ÷±¸ Ç¥¸é¿¡ A, BÇ׿ø, Ç÷¾×¼Ó¿¡ A,B¿¡ ´ëÇÑ Ç×ü¸¦ °¡ÁöÁö ¾Ê´Â´Ù.
  
  -OÇü Ç÷¾×Çü£­ÀûÇ÷±¸ Ç¥¸é¿¡ A, BÇ׿ø ¸ðµÎ¸¦ °¡ÁöÁö ¾Ê°í, Ç÷¾×¼Ó¿¡ A, B¿¡ ´ëÇÑ Ç׿øÀ» ¸ðµÎ °¡Áø´Ù.
  
  ´ë°³ À̰ÍÀ» ÀÌ¿ëÇÏ¿© ¼öÇ÷ÀǠŸ´ç¼º ¿©ºÎ¸¦ Á¶»çÇÑ´Ù. ¸¸¾à AÇü Ç÷¾×ÇüÀ» °¡Áø »ç¶÷ÀÇ ÇǸ¦ BÇü Ç÷¾×ÇüÀÇ »ç¶÷¿¡°Ô ¼öÇ÷Çϸé BÇü Ç÷¾×ÇüÀ» °¡Áø ÀÚÀÇ ÇǼӿ¡ Àִ A¿¡ ´ëÇÑ Ç×ü¶§¹®¿¡ µé¾î¿Â AÇüÀÇ ÀûÇ÷±¸´Â ÆÄ±«µÇ°Å³ª, ÀÀÁýÀÌ µÈ´Ù. OÇüÀÇ Ç÷¾×ÇüÀ» °¡Áø »ç¶÷ÀÇ Ç÷¾×ÀÇ ÀûÇ÷±¸´Â Ç¥¸é¿¡ A, BÀÇ ¾î¶°ÇÑ ¹°Áúµµ °¡Áö°í ÀÖÁö ¾Ê¾Æ¼­ ¾î¶°ÇÑ Ç÷¾×ÇüÀ» °¡Áø »ç¶÷¿¡°Ô ¼öÇ÷ÇØµµ ¹ÝÀÀÀ» ÀÏÀ¸Å°Áö ¾Ê´Â´Ù. À̿͠°°Àº ¿ø¸®·Î ABÇüÀÇ Ç÷¾×ÇüÀ» °¡Áø »ç¶÷Àº Ç÷¾×¼Ó¿¡ A, B¿¡ ´ëÇÑ Ç×ü¸¦ ¸ðµÎ °¡Áö°í ÀÖÁö ¾ÊÀ¸¹Ç·Î ¾î¶°ÇÑ Ç÷¾×ÇüÀ̶󵵠¹ÞÀ» ¼ö°¡ ÀÖ´Ù.
  
  2. RhÇ÷¾×Çü
  
  ÀûÇ÷±¸Ç¥¸é¿¡ Àִ D¶ó´Â ¹°ÁúÀ» ±âÁØÀ¸·Î ÇÏ¿© Ç÷¾×ÇüÀ» ³ª´©´Â ¹æ¹ý. ¸¸¾à D¶ó´Â ¹°ÁúÀÌ ÀûÇ÷±¸ÀǠǥ¸é¿¡ Á¸ÀçÇϸé Rh(+), Á¸ÀçÇÏÁö ¾ÊÀ¸¸é Rh(£­)¶ó°í ÇÑ´Ù. ABOÇ÷¾×Çü¿¡¼­¿Í °°ÀÌ Rh(+)Ç÷¾×ÇüÀ» °¡Áö´Â »ç¶÷ÀÇ ÇǼӿ¡´Â D¶ó´Â ¹°Áú¿¡ ´ëÇÑ Ç×ü°¡ Á¸ÀçÇÏÁö ¾ÊÁö¸¸ Rh(£­)Ç÷¾×ÇüÀ» °¡Áø »ç¶÷ÀÇ ÇǼӿ¡´Â D¿¡ ´ëÇÑ Ç×ü°¡ Á¸ÀçÇÑ´Ù. ABOÇ÷¾×Çü°ú ¸¶Âù°¡Áö·Î ¼öÇ÷ÀǠŸ´ç¼ºÀ» °áÁ¤Çϴµ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • factor III
    Á¦3ÀÎÀÚ
  • atomic group
    ¿øÀÚ´Ü
  • ABO blood group system
    ABOÇ÷¾×Çüü°è
  • amino group
    ¾Æ¹Ì³ë±â
  • basic food group
    ±âÃʽÄǰ±º
  • blood group
    Ç÷¾×Çü
  • blood group incompatibility
    Ç÷¾×ÇüºÎÀûÇÕ
  • blood group system
    Ç÷¾×Çüü°è
  • coliform group
    ´ëÀå±Õ±º
  • complementation group
    »óº¸¼ºÁý´Ü
  • control group
    ´ëÁ¶±º
  • determinant group
    °áÁ¤±º
  • diagnosis related group
    Æ÷°ý¼ö°¡Á¦
  • directive group therapy
    Áö½ÃÁý´Ü¿ä¹ý
  • end group
    ¸»´Ü±â
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • group
    ¹«¸®, ±º, Áý´Ü, ¸ðµÒ
  • amino group
    ¾Æ¹Ì³ë±â
  • diagnosis related group
    Æ÷°ý¼ö°¡Á¦
  • high risk group
    °íÀ§Ç豺
  • low risk group
    ÀúÀ§Ç豺
  • self-help group
    ÀÚ°¡µµ¿òÁý´Ü
  • group practice
    Áý´Ü°³¾÷
  • blood group system
    Ç÷¾×Çü±º
  • fiber
    ¼¶À¯
  • afferent nerve fiber
    µé½Å°æ¼¶À¯
  • nerve fiber
    ½Å°æ¼¶À¯
  • parallel fiber
    ÆòÇ༶À¯
  • postganglionic nerve fiber
    ½Å°æÀýÀÌÈļ¶À¯
  • preganglionic nerve fiber
    ½Å°æÀýÀÌÀü¼¶À¯
  • Purkinje fiber
    ½ÉÀåÀüµµ±ÙÀ°¼¶À¯, Ǫ¸£Å°´Ï¿¡¼¶À¯
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ABO blood group system
    ¿¡À̺ñ¿ÀÇ÷¾×Çü±º
  • amino group
    ¾Æ¹Ì³ë±â
  • atomic group
    ¿øÀÚ´Ü
  • group antigen
    ±ºÇ׿ø
  • group audiometry
    Áý´Üû·Â°Ë»ç
  • group-specific antigen
    ±ºÆ¯ÀÌÇ׿ø
  • basic food group
    ±âÃʽÄǰ±º
  • blood group
    Ç÷¾×Çü
  • blood group incompatibility
    Ç÷¾×ÇüºÎÀûÇÕ
  • blood group system
    Ç÷¾×Çü±º
  • blood group specific substance
    Ç÷¾×ÇüƯÀ̹°Áú
  • borderline group
    °æ°è±º
  • coliform group
    ´ëÀå±Õ±º
  • complementation group
    »óº¸¼ºÁý´Ü
  • complementophil group
    º¸Ã¼Ä£È­±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • group III fiber
    Á¦¥²¤Çí·A.
  • group III fiber
    Á¦¥²±º¼¶À¯(ÏØàéë«).
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • group I fiber
    Á¦¥°¤Çí·A(ð¯ìéÏØàéë«).
  • group I fiber
    Á¦¥°±º¼¶À¯(ð¯ìéÏØàéë«).
  • group II fiber
    Á¦¥±¤Çí·A.
  • group II fiber
    Á¦¥± ±º¼¶À¯(ÏØàéë«).
  • group IV fiber
    Á¦¥³¤Çí·A.
  • group IV fiber
    Á¦¥³±º¼¶À¯(ÏØàéë«).
  • DSM-III
    Á¤½ÅÀå¾Ö(º´)Áø´ÜÅë°èÆí¶÷ Á¦ 3ÆÇ
  • DSM-III-R
    Á¤½ÅÀå¾Ö(º´)Áø´ÜÅë°èÆí¶÷ Á¦ 3ÆÇ °³Á¤ÆÇ
  • Sudan III
    ¼ö´Ü III
  • antithrombin III
    Çׯ®·Òºó III
  • apolipoprotein C-III
    ¾ÆÆ÷Áö´Ü¹é C-III
  • arsenazo III dye
    ¾Æ¸£¼¼³ªÁ¶<ºñ¼Ò¾ÆÁ¶> III ¿°·á
  • hyperlipoproteinemia type III
    °íÁö´Ü¹éÇ÷Áõ III
  • hyperproteinemia type III
    ´Ü¹é°úÀ×Ç÷(Áõ) III Çü
  • hypersensitivity reactions,type iii(imune complex-mediated)
    IIIÇü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • group III fiber
    Á¦¥²±º¼¶À¯(ÏØàéë«).
  • group III fiber
    Á¦¥²¤Çí·A.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • group I fiber
    Á¦¥°±º¼¶À¯(ð¯ìéÏØàéë«).
  • group I fiber
    Á¦¥°¤Çí·A(ð¯ìéÏØàéë«).
  • group II fiber
    Á¦¥± ±º¼¶À¯(ÏØàéë«).
  • group II fiber
    Á¦¥±¤Çí·A.
  • group IV fiber
    Á¦¥³±º¼¶À¯(ÏØàéë«).
  • group IV fiber
    Á¦¥³¤Çí·A.
  • ascending nerve fiber, climbing fiber
    ¿À¸§¼¶À¯
  • perforating fiber [sharpeys fiber]
    ½Ã¸àÆ®Áú°üÅë¼¶À¯
  • antithrombin III
    Çׯ®·Òºó III
  • apolipoprotein C-III
    ¾ÆÆ÷Áö´Ü¹é C-III
  • arsenazo III dye
    ¾Æ¸£¼¼³ªÁ¶<ºñ¼Ò¾ÆÁ¶> III ¿°·á
  • hyperlipoproteinemia type III
    °íÁö´Ü¹éÇ÷Áõ III
  • hyperproteinemia type III
    ´Ü¹é°úÀ×Ç÷(Áõ) III Çü
  • hypersensitivity reactions,type iii(imune complex-mediated)
    IIIÇü
  • oculomotor nerve (iii)
    ´«µ¹¸²½Å°æ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Group of isogenous chondrocyte
    ¿¬°ñ¼¼Æ÷¹«¸®
    [¿¾ ¿ë¾î] ¿¬°ñ¼¼Æ÷±ºÁý
  • Third arch (III)
    ¼Â°±ÁÀÌ
    [¿¾ ¿ë¾î] Á¦»ï±Ã
  • Oculomotor nerve (III)
    ´«µ¹¸²½Å°æ
    [¿¾ ¿ë¾î] µ¿¾È½Å°æ
  • Perforating fiber [Sharpey`s fiber]
    ½Ã¸àÆ®Áú°üÅë¼¶À¯
    [¿¾ ¿ë¾î] ½Ã¸àÆ®Áú°üÅë¼¶À¯
  • Ascending nerve fiber, Climbing fiber
    ¿À¸§¼¶À¯
    [¿¾ ¿ë¾î] »óÇà½Å°æ¼¶À¯
  • Perforating fiber
    °üÅë¼¶À¯
    [¿¾ ¿ë¾î] °üÅë¼¶À¯
  • Muscle fiber
    ±ÙÀ°¼¶À¯
    [¿¾ ¿ë¾î] ±Ù¼¶À¯
  • Spiral fiber
    ³ª¼±½Å°æ¼¶À¯
    [¿¾ ¿ë¾î] ³ª¼±½Å°æ¼¶À¯
  • Anular reticular fiber
    µ¹¸²¼¼¸Á¼¶À¯
    [¿¾ ¿ë¾î] À±»ó¼¼¸Á¼¶À¯
  • Afferent nerve fiber
    µé½Å°æ¼¶À¯
    [¿¾ ¿ë¾î] ¼öÀԽŰ漶À¯
  • Zonular fiber
    ¶ì¼¶À¯
    [¿¾ ¿ë¾î] ¼Ò´ë¼¶À¯
  • Myelinated nerve fiber
    ¸»ÀÌÁý½Å°æ¼¶À¯
    [¿¾ ¿ë¾î] À¯¼ö½Å°æ¼¶À¯
  • Gustatory nerve fiber
    ¹Ì°¢½Å°æ¼¶À¯
    [¿¾ ¿ë¾î] ¹Ì·Ú½Å°æ¼¶À¯
  • Nonmyelinated nerve fiber
    ¹Î¸»ÀÌÁý½Å°æ¼¶À¯
    [¿¾ ¿ë¾î] ¹«¼ö½Å°æ¼¶À¯
  • Matrix fiber
    ¹ÙÅÁÁú¼¶À¯
    [¿¾ ¿ë¾î] ±âÁú¼¶À¯
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end group spine
    ±ê³¡°¡½Ã
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dietary fiber
    ½ÄÀ̼¶À¯(ãÝìÈàéë«)
  • DNA polymerase III
    DNA Æú¸®¸Ó·¹À̽º III
  • enzyme III
    È¿¼Ò(ý£áÈ) III
  • exonuclease III
    ¿¢¼Ò´©Å¬¸®¿¡À̽º III
  • HTLV-III
    (å²) human T cell lymphostrophic virus
  • ribonuclease III
    ¶óÀ̺¸´ºÅ¬¸®¿¡À̽º III
  • ABO blood group (type) system
    ABOÇ÷¾×Çü (úìäûúþ) ½Ã½ºÅÛ
  • acetyl group
    ¾Æ¼¼Æ¿±â(Ðñ)
  • acyl group
    ¾Æ½Ç±â(Ðñ)
  • alcoholic hydroxyl group
    ¾ËÄݼº(àõ) ÇÏÀ̵å·Ï½Ç±â(Ðñ)
  • aldehyde group
    ¾Ëµ¥ÇÏÀ̵å±â(Ðñ)
  • amino group
    ¾Æ¹Ì³ë±â(Ðñ)
  • angle methyl group
    ¾Þ±Û¸ÞÆ¿±â(Ðñ)
  • aryl group
    ¾Æ¸±±â(Ðñ)
  • azide group
    ¾ÆÀÚÀ̵å±â(Ðñ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • control group
    ´ëÁ¶±º
  • group file
    ±×·ì È­ÀÏ
  • high risk group
    °íÀ§Çèµµ±º
  • JPEG [=joint photographic expert group]
    JPEG
  • fiber
    ¼¶À¯
  • fiber distributed data interface(FDDI)
    ±¤³×Æ®¿öÅ©
  • longitudinal fiber
    ¼¼·Î¼¶À¯, Á¾ÁÖ¼¶À¯
  • motor fiber
    ¿îµ¿(½Å°æ)¼¶À¯
  • muscle fiber
    ±Ù¼¶À¯
  • purkinje's fiber
    ǮŲ¿¹¼¶À¯
  • radial fiber
    ºÎä»ì¼¶À¯, ¹æ»ç¼¶À¯
  • reticular fiber
    ¼¼¸Á¼¶À¯
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
AT III angiotensin III; antithrombin III
ML I, II, III, IV mucolipidosis I, II, III, IV
AGPA American Group Practice Association; American Group Psychotherapy Association
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
Group III group
A III Angiotensin III
ANG III Angiotensin III
AT III Anti-thrombin III
AP III Antipyrylazo III
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Class III
    3±Þ
    µ¿ÀǾî=mesiocclusion. ÇϾǰú ÇÏ¾Ç Ä¡¾Æ°¡ »ó¾Ç¿¡ ºñÇØ Àü¹æ¿¡ À§Ä¡ÇÑ °æ¿ì.
  • class III malocclusion
    Á¦ III±Þ ºÎÁ¤±³ÇÕ
  • laminar III
    Á¦ 3Ãþ
  • lues III
    ¸Åµ¶ 3±â
    1. Èı⠸ŵ¶Àº ¸Å¿ì µå¹°´Ù. 2. ½É¸Æ°ü°è º´º¯ÀÌ 80¡­85%, ÁßÃ߽Űæ°è º´º¯ 5¡­10%, ³ª¸ÓÁö´Â °£À̳ª ´Ù¸¥ ºÎÀ§¿¡ °í¹«Á¾ÀÌ ¹ß»ýÇÑ´Ù.
  • platelet fector III
    Ç÷¼ÒÆÇ Á¦ »ï ÀÎÀÚ
  • pseudo class III
    °¡¼º III ±Þ
  • pseudotumour :

    pseudounipolar bipolar III disorder

    °¡¼º ´Ü±Ø¼º ¾ç±Ø¼º III Àå¾Ö, °¡¼º ´Ü±Ø¼º ¾ç±Ø¼º III º´
  • transverse facial fracture : µ¿ÀǾî=Le Forte III fracture.

    transverse facial vein

    °¡·Î ¾ó±¼ µ¿¸Æ
  • true class III
    Áø¼º III±Þ ºÎÁ¤ ±³ÇÕ
  • type III
    3Çü
  • ABO blood group system
    ABO Ç÷¾×Çü°è, ABO Ç÷¾×Çü °èÅë
    A, B´Â ¿ì¼º, O´Â ¿­¼ºÀ¸·Î¼­, A, B, AB, OÇüÀÌ ÀÖ´Ù.
  • allyl group
    ¾Ë¸±±º
  • axon group
    Ãà»è ±º
  • blood group
    Ç÷¾×Çü
    µ¿ÀǾî=blood ty
  • blood group incompatibility
    Ç÷¾×Çü ºÎÀûÇÕ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
group III mycobacteria Mycobacteria that are either colourless or that slowly produce a light yellow pigment when grown in the presence of light. Organisms placed in this group belong to the species Mycobacterium intracellulare.
Synonym: nonchromogens.
(05 Mar 2000)
angiotensin III <chemical> A heptapeptide formed by the enzymatic hydrolysis of angiotensin II. It has greater activity than angiotensin II for stimulating aldosterone synthesis and in the release of prostaglandins but only 20% of the pressor activity.
Chemical name: Angiotensin II, 1-de-L-aspartic acid-
(12 Dec 1998)
annexin III <enzyme> A protein of the annexin family that catalyses the conversion of 1-d-inositol 1,2-cyclic phosphate and water to 1-d-myo-inositol 1-phosphate.
Chemical name: 1-D-myo-Inositol-1,2-cyclic-phosphate 2-inositolphosphohydrolase
Registry number: EC 3.1.4.36
(12 Dec 1998)
antithrombin III <haematology> Antithrombin III is a protein which stimulates the removal of blood clots in the bloodstream.
Small blood clots form normally within the bloodstream, but are normally dissolved via the bodys antithrombin III.
Conditions that may have an associated low value of antithrombin III include: liver disease and DIC. Normal values are: 0.20 to 0.45 mg/ml or more than 50% of the laboratory control value.
Conditions where there is a deficiency of this important protease inhibitor can result in a condition of hypercoagulation, resulting in an increased risk for blood clot formation.
Inheritance: autosomal dominant.
(13 Jan 1998)
apolipoprotein C-III <biochemistry> An apolipoprotein found in VLDL, HDL, and chylomicrons.
(05 Mar 2000)
arsenazo III <chemical> Metallochrome indicator that changes colour when complexed to the calcium ion under physiological conditions. It is used to measure local calcium ion concentrations in vivo.
Pharmacological action: dyes, indicators and reagents.
Chemical name: 2,7-Naphthalenedisulfonic acid, 3,6-bis((2-arsonophenyl)azo)-4,5-dihydroxy-
(12 Dec 1998)
arteriae intercostales posteriores III-XI posterior intercostal arteries 3-11
band III protein <protein> A 90 kD protein embedded in the surface of the human erythrocyte membrane, identified as the major anion transport/exchange protein. When the red blood cell is in the lungs, brings chlorine ion into the cell in exchange for bicarbonate.
Analogous proteins exist in other erythrocytes. A dimeric transmembrane glycoprotein, with binding sites for many cytolasmic proteins, including ankyrin, on its cytoplasmic domain.
(18 Nov 1997)
palpebra III The semilunar fold formed by the palpebral conjunctiva at the medial angle of the eye, a fold of the conjunctival mucous membrane found in many animals; normally partially hidden in the medial canthus of the eye when at rest, it may be extended to cover part or all of the cornea in a winking-like action to clean the cornea, as in birds.
Synonym: membrana nictitans, nictitating membrane, palpebra III, palpebra tertia, third eyelid.
Synonym: plica lunata, plica semilunaris of eye, semilunar conjunctival fold.
(05 Mar 2000)
ramus collateralis arteriarum intercostalium posteriorum III-XI Branch arising near angle of rib and descending to run along superior border of rib below; distribution: lower half of intercostal spaces 3-11; anastomoses: collateral branches of anterior intercostal arteries.
Synonym: ramus collateralis arteriarum intercostalium posteriorum III-XI.
(05 Mar 2000)
ramus cutaneus medialis rami dorsalis arteriarum intercostalium posteriorum III-XI Medial cutaneous branch of dorsal branch of posterior intercostal arteries.
See: medial cutaneous branch.
(05 Mar 2000)
ramus dorsalis arteriarum intercostalium posteriorum III-XI Terminal branch (with ventral branch) of the 3rd through 11th posterior intercostal arteries, distributed to thoracic portion of posterior vertebral column, spinal cord and environs, and back.
Synonym: ramus dorsalis arteriarum intercostalium posteriorum III-XI.
(05 Mar 2000)
malocclusion, angle class III Malocclusion in which the mandible is anterior to the maxilla as reflected by the first relationship of the first permanent molar (mesioclusion).
(12 Dec 1998)
virus III of rabbits An obsolete name for a latent herpesvirus infection of rabbits.
Origin: the third strain isolated, used for study
(05 Mar 2000)
glycogen storage disease type III <disease> An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system).
The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups type IIIa and type IIIb being the most prevalent.
Inheritance: autosomal recessive
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fiber
    ¼¶À¯
  • acrylic fiber
    ¾ÆÅ©¸±¼¶À¯
  • carbon fiber
    ź¼Ò ¼¶À¯
  • dietary fiber
    À½½Ä ¼¶À¯
  • fiber
    ¼¶À¯Áú;´Ü¼¶À¯;¼º°Ý;¼ö¿°»Ñ¸®
  • fiber art
    ÆÄÀ̹ö¾ÆÆ®
  • fiber optics
    ¼¶À¯ ±¤ÇÐ(À¯¸®³ª ÇÃ¶ó½ºÆ½ ¼¶À¯°üÀ» ÅëÇÏ¿© ±¤»óÀ» ±¼Àý½ÃÄÑ Àü´ÞÇÏ´Â ±â¼ú)
  • glass fiber(fibre)
    À¯¸® ¼¶À¯
  • graphite fiber
    ±×·¡ÆÄÀÌÆ® ÆÄÀ̹ö(¼¶À¯)
  • nerve fiber
    ½Å°æ¼¶À¯
  • staple fiber
    Àΰß;½ºÇÁ
  • age-group
    ¿¬·É Áý´Ü
  • group
    Áý´Ü,¶¼¸¦ Áþ´Ù,ºÐ·ùÇÏ´Ù
  • Group of 77
    77°³±¹ ±×·ì(UNÀÇ ¹«¿ª°³¹ß ȸÀÇ(UNCTAD)ÀÇ È¸¿øÀÎ ¹ßÀü µµ»ó±¹ ±×·ì)
  • Group of Seven
    G;7 ¼±Áø 7°³±¹ ±×·ì
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á